Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of inflation and pricing pressures in the global markets. While R&D investment, market competitiveness, regulatory scrutiny, and domestic price regulations are expected to shape the growth of generics and injectable products, concerns such as price control and customs duties on medical equipment will continue to bother the healthcare industry in 2023. The industry believes that in view of India's G20 Presidency, digital health innovation, achieving universal health coverage, improving healthcare infrastructure and delivery will continue to be the key driving factors in 2023.
The diagnostic test kit developed by the Thiruvananthapuram institute can detect coronavirus in 10 minutes, and the sample to result time will be less than two hours, Vardhan tweeted. A total of 30 samples can be tested in a single batch on a single machine, he said.
The Rhesus macaque monkeys, used worldwide in medical research, are believed to be the best non-human primates for such studies.
The academic centrepiece of this initiative will be an integrated dual degree MD-PhD programme aimed at creating a new breed of physician-scientists, who will pursue careers in clinical research to develop new treatments and healthcare solutions, driven by a bench-to-bedside philosophy, a statement said.
Swarms of ants infested every nook and corner of the village, including houses, roads, fields and trees, throwing the normal lives out of gear. Many have been beaten by these ants, causing swelling and irritation on the skin.
It also assured that the amount of medical insurance coverage under the Ayushman Bharat scheme would be doubled from Rs 5 lakh to Rs 10 lakh.
The rapid molecular test is highly accurate and easy to use, making it a prime candidate for use in settings with limited testing capabilities, according to the researchers.
One of the biggest lessons for cities fighting the Covid-19 pandemic has been the criticality of access to data. Mumbai, which has shown significant success in managing the second wave of the pandemic, is a case in point, reports Shivani Shinde.
India's top vaccinologist Gagandeep Kang stressed the need to develop better vaccines that can deal with new variants, and strengthening of the regulatory mechanisms.
The three Indian companies are Alpha Design Technologies Pvt Ltd, Bharat Forge Ltd and Medha Servo Drives Pvt Ltd, the space organisation said in a statement on Friday.
'Never believed that we humans have the capability at this time to create such a virus'
Taking lessons from that, I would think seamless digital payments is something you have to clearly have a roadmap for, the FM said.
This doctor couple put their faith in India. And in return India has put faith in them.
'If the government doesn't subsidise, it would be a huge setback in the fight against COVID-19'
Dr Sangeeta N Bhatia, director, Laboratory for Multiscale Regenerative Technologies at the Massachusetts Institute of Technology, has been chosen to the newest class of the prestigious Howard Hughes Medical Institute investigators.
Chari, 43, will serve as the commander while NASA's Tom Marshburn will be pilot and ESA's Matthias Maurer will serve as a mission specialist for the SpaceX Crew-3 mission to the ISS, which is expected to launched next year.
Niclosamide, a drug on the World Health Organisation's list of essential medicines, has been used to treat tapeworm infestation for more than 50 years. The oral antiviral drug was also used to treat patients during the SARS outbreak of 2003-04.
Hinduja Group's business process management entity, Hinduja Global Solutions Limited (HGS) said on Wednesday that it has entered into definitive agreements to divest its Healthcare Services business to funds affiliated with Baring Private Equity Asia (BPEA), at an enterprise value of $1.2 bilion. The deal is subject to closing adjustments, and is expected to complete within 90 days, subject to shareholder and other regulatory approvals. "The cash that will come in as a result of this transaction will be deployed to growing the business as well as looking at buying some capabilities...where capabilities are important for being able to do a good job of customer experience transformation.
'A probable positive patient walking into a centre is not an ideal situation.'
In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.
The health ID will contain information about medical data, prescriptions and diagnostic reports and summaries of previous discharge from hospitals for ailments. The mission is expected to bring efficiency and transparency in healthcare services in the country.
While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up very rapidly, reports Sohini Das.
PharmaSecure, a US based company, is in talks with Indian drug majors to implement a new, cost-effective, SMS-based technology that would allow consumers to check the authenticity of the drug - in a strip, tablet or a bottle - by directly getting in touch with the manufacturer.
The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments available in India to 12.
While there is a shortage of testing kits, manpower and capacities, India does not have other scalable testing options.
From scanning hospital entrants to disinfecting hospital areas and floors, robots are being roped in for tasks considered high-risk, says Peerzada Abrar.
The annual award recognizes individuals for contributions that advance the technology of clinical laboratory sciences.
The Corosure Kit has received ICMR approval with the highest score and DCGI approved with a very high sensitivity and specificity.
'Almost 70 per cent production time of a vaccine is dedicated to quality control, which is done through several hundred tests.'
Six Indian-American students have grabbed top positions in a competition of young innovators.
The UP government is also planning to free up its own land from illegal encroachment to set up these new cow- shelters in "safe locations" and with full facility for fodder and water.
The arrival of summer in India may have raised hopes that hot and humid weather could slow the COVID-19 progression but virologist Naga Suresh Veerapu believes that outbreak and pandemic occurrences often do not follow seasonality.
Replying to a short duration discussion on COVID-19 management in Rajya Sabha, the minister said technology transfer to several companies has started and they will begin production in the coming days to reduce vaccine shortage in the country.
He invented a skin patch that can detect a silent heart attack 6 hours before it happens!
AQ Khan, a controversial scientist known as the father of Pakistan's clandestine nuclear programme, passed away here on Sunday after a brief illness. He was 85.
Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With More drugmakers in line to launch the drug soon, the prices may see a further erosion.
India is the fourth worst-hit nation by the pandemic after the United States, Brazil and Russia.
A longer shelf life is critical, given many makers have started manufacturing vaccines and stockpiling them, so as to make them available in the market immediately after approval, reports Sohini Das.
The Union health minister said of the total active COVID-19 cases in the country, 1.5 per cent are on oxygen support and 2.34 per cent are in ICUs.
